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GENERAL INTRODUCTION 
Acute bovine pneumonie pasteurellosis is primarily 
caused by Pasteurella haemolvtica. Currently, 16 serotypes 
(1-16) of P. haemolvtica have been identified within two 
biotypes (A and T). Pasteurella haemolvtica serotype 1, 
which is of the A biotype, is the type most frequently 
isolated from pneumonic bovine lungs (Frank, 1986). This 
bacterium is one of several etiologic agents associated with 
the bovine respiratory disease complex, and is considered to 
be the agent associated with severe morbidity and mortality 
of cattle affected with the bovine respiratory disease 
complex (Yates, 1982). Pneumonic pasteurellosis occurs 
primarily in calves, associated with stressful conditions 
such as weaning, transportation, and commingling of cattle 
from different sources. 
Reproduction of pneumonic pasteurellosis by 
introduction of P. haemolvtica into the respiratory tract is 
sometimes met with failure, although it has been stated that 
P. haemolvtica can and does cause pneumonia by itself, 
without the assistance of other pathogens (Thomson, 1980). A 
blood-borne route of arrival of P. haemolvtica to the bovine 
lung has been proposed (Thomas et al., 1989), although there 
has generally been scanty support of this hypothesis (Carter, 
1954) . 
Humoral immune responses of cattle to P. haemolvtica 
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have been extensively studied, and antibody responses to 
certain components of P. haemolvtica have been proposed to be 
associated with protective immunity. The cell-mediated 
branch of the bovine immune response, however, has not been 
evaluated as a factor in protective immunity against P. 
haemolvtica. The objectives of this study were i) to 
establish a caprine model of penumonic pasteurellosis by 
comparing the pulmonary responses to intratracheal, 
intravenous, and intratonsillar routes of inoculation with P. 
haemolvtica. ii) to develop techniques and conditions 
necessary to evaluate cell-mediated immune responses to P. 
haemolvtica. and iii) to assess the cell-mediated immune 
responses of cattle after vaccination or infection with P. 
haemolvtica. 
Dissertation format 
This dissertation includes two manuscripts, the first of 
which has been published in Veterinary Research 
Communications. The second manuscript has been prepared for 
submission to Infection and Immunity. Review of the 
literature precedes the first manuscript, and a general 
summary and discussion follows the second manuscript. 
References cited in the manuscripts are listed at the end of 
each manuscript. Literature cited in the general 
introduction, literature review, and general summary and 
discussion appears in the same format as the first 
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manuscript, and is located after the general summary and 
discussion. Three appendices conclude the dissertation, with 
the first including additional methods that were used in 
Paper 1. The second appendix contains methods and results of 
antileukotoxin antibody titers from Paper 2. The third 
appendix includes data from preliminary studies of nasal 
colonization of calves by P. haemolvtica. The nasal 
colonization studies were discontinued due to technical 
dificulties. 
The Ph.D. candidate, Brad M. DeBey, was the principal 




The naming of bovine pasteurellosis (Shirlaw, 1938) 
resulted from observations of two separate syndromes in 
cattle that were associated with Pasteurella species. It was 
known that Pasteurella species were associated with 
hemorrhagic septicemia and pneumonia in cattle (Jones, 1921). 
The two syndromes were classified separately, with bovine 
pasteurellosis characterized as the pneumonic form, and 
usually associated with P. haemolvtica (Newsom and Cross, 
1932) . 
Pneumonic pasteurellosis of cattle was often associated 
with transportation of cattle, hence, the names ^shipping 
fever', or ^transit fever' (Kinsley, 1915, Marshall, 1922, 
Hepburn 1925, Anderson, 1939). Numerous etiologic agents 
have been determined to be associated with bovine respiratory 
tract disease (Yates, 1982), however, P. haemolvtica or P. 
multocida were regarded as the cause of clinical signs and 
death loss (Collier, 1968). Thomson (1980) stated that P. 
haemolvtica can and does cause shipping fever by itself, 
although parainfluenza-3 virus (Pl-3 virus), infectious 
bovine rhinotracheitis virus (IBR virus), bovine respiratory 
syncytial virus, or mycoplasmas may facilitate the process. 
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Virulence factors of Pasteurella haemolvtica 
Fimbriae Fimbriae have been demonstrated on P. 
haemolvtica grown in vitro (Morck et al., 1987) and on 
bacterial cells recovered in pulmonary lavage fluid from an 
experimentally infected calf (Morck et al., 1988). Fimbriae 
were proposed to promote adhesion of P. haemolvtica to upper 
respiratory tract mucosal surfaces, and structures resembling 
fimbriae were demonstrated on P. haemolvtica that were 
adherent to tracheal epithelium in a naturally infected calf 
(Morck et al., 1989). 
Capsular polvsaccharide Electron microscopic studies 
(Gilmour et al., 1985, Morck et al., 1988) have demonstrated 
that Pasteurella haemolvtica produces a glycocalyx (capsule) 
composed in part of serotype-specific polysaccharides (Adlam 
et al., 1986). Morck et al. (1988) demonstrated intimate 
association of encapsulated P. haemolvtica to alveolar 
epithelium, proposing that capsular material may aid in 
adherence of the organism to alveolar epithelium. 
Capsular polysaccharide of P. haemolvtica released into 
lung alveoli in the early stages of infection may alter 
phagocytic cell function. After incubation of capsular 
polysaccharide of P. haemolytica with bovine neutrophils 
(Czuprynski et al., 1989) or alveolar macrophages (Czuprynski 
et al., 1991), a marked decrease in phagocytosis and killing 
of the organism was demonstrated. 
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Leukotoxin Benson et al. (1978) first described in 
vitro cytotoxicity caused by P. haemolvtica. The cytotoxic 
factor was later identified as leukotoxin, which is present 
in culture supernatants as a protein polymer with a molecular 
weight greater than 400 kilodaltons (kDa) (Chang et al., 
1987). The protein that confers leukotoxic activity to the 
complex has a molecular weight of 102 kDa (Lo, 1990) . 
Leukotoxin of P. haemolvtica is a member of a family of 
toxins termed Repeats in Toxin (RTX) that are genetically 
related (Welch et al.,1992). The Escherichia coli hemolysin 
(HlyA) and the Bordetella pertussis adenylate 
cyclase/hemolysin (CyaA) are also RTX toxins. 
Leukotoxin elaborated from P. haemolvtica is a pore-
forming cytolysin (Clinkenbeard et al., 1989) that causes 
lysis of bovine neutrophils (Baluyut et al., 1981), 
peripheral blood monocytes, lymphocytes and alveolar 
macrophages (Shewen and Wilkie, 1982), and platelets 
(Clinkenbeard and Upton, 1991). In lower, nonlethal 
concentrations, leukotoxin reduces functional capabilities of 
bovine neutrophils (Czuprynski and Noel, 1990), alveolar 
macrophages (Richards and Renshaw, 1986) and lymphocytes 
(Czuprynski and Ortiz-Carranza 1992). 
Shewen and Wilkie (1983a) demonstrated leukotoxin 
production by all of the 12 recognized serotypes of P. 
haemolvtica. The authors concluded that leukotoxin 
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production solely by serotype 1 was not the factor related to 
the nearly unique involvement of P. haemolvtica serotype l in 
bovine pneumonic pasteurellosis. 
Lipopolvsaccharide Pasteurella haemolvtica 
lipopolysaccharide (LPS) is similar to LPS produced by other 
gram-negative bacteria, and is composed of lipid A, core 
oligosaccharide, and an antigenic polysaccharide chain (O 
antigen) (Confer et al., 1990). Biological properties of P. 
haemolvtica LPS are similar to LPS of Escherichia coli. with 
intravascular injections of P. haemolvtica LPS causing 
increased pulmonary arterial pressure and decreased cardiac 
output (Keiss et al., 1964). 
The LPS of P. haemolvtica probably contributes a major 
component to the inflammatory response that occurs in 
pneumonic pasteurellosis. Experimentally, administration of 
P. haemolvtica LPS to calves induces release of 
prostaglandins, serotonin and histamine (Emau et al., 1984), 
and intrabronchial instillation of P. haemolvtica LPS in 
sheep causes acute pneumonia (Brogden et al., 1984). 
However, Confer et al. (1986a) demonstrated that serum 
antibody response to P. haemolvtica LPS in calves vaccinated 
for P. haemolvtica is not important for resistance to 
experimental challenge with the organism. 
Experimental production of pneumonic pasteurellosis 
Controversy exists as to the methods of choice to 
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experimentally produce pneumonic pasteurellosis. Many 
techniques have been attempted, some successfully and others 
unsuccesfully, to reproduce the disease. 
Intranasal inoculation of P. haemolvtica was 
unsuccessful in producing disease in several studies. 
Horlein and Marsh (1957) exposed calves to nasal exudates 
from calves with natural cases of shipping fever, with no 
disease resulting from the inoculations. Carter (1956) 
inoculated 21 calves intranasally with P. haemolvtica; 
although not all calves were necropsied after inoculation, 
pneumonic lesions from which P. haemolvtica was isolated were 
present only in two calves. 
Attempts of experimental infections using intratracheal 
or intrabronchial injection of P. haemolvtica have been 
reported to have variable results of producing pneumonia. 
Early studies often indicated that intratracheal injection of 
P. haemolvtica did not consistently produce pneumonic lesions 
(Carter, 1954) (Gale and Smith, 1958) (Heddleston et al., 
1962). In the more important of these studies (Gale and 
Smith, 1958), 16 calves were intratracheally inoculated with 
up to 1.8 X 10^1 CFU of £. haemolvtica. with no signs of 
disease occurring, and pneumonic lesions were not found in 
any of the 16 calves at necropsy. 
More recent studies, however, indicate more consistent 
production of pneumonia with intratracheal inoculation of P. 
9 
haemolvtica. Gibbs et al., (1984) reproduced pneumonic 
pasteurellosis by intratracheal inoculation of conventional 
calves with 2.0 X 10^° to 8 X 10^^ cpy of haemolvtica 
given five inoculations during three consecutive days. At 
necropsy, approximately 70% of the anterior lung lobes were 
pneumonic in four of four calves inoculated. Ames, et al. 
(1985) inoculated calves intratracheally in groups of three 
with varying doses of logarithmic growth phase P. haemolvtica 
cultures. At necropsy, pneumonia was present at up to 38.3% 
of the total lung volume in calves inoculated with 1 X 10® 
CPU of P. haemolvtica. Wilkie et al. (1980) produced 
pneumonic lesions in 57.1% of calves by intrabronchial 
inoculation of 2 X 10® or 2 X 10^ CPU of P. haemolvtica. 
Authors have cautioned readers about intratracheal 
inoculation techniques often used to produce pneumonic 
pasteurellosis. Gilmour et al. (1975) stated that studies in 
which large doses of bacteria were given directly into the 
lung should be treated with reserve, since very large numbers 
of organisms might be expected to produce a pathological 
change. Jericho (1987) stated that inoculation of animals by 
methods that are unnatural (i.e. intratracheal injection) may 
produce tissue responses with visual appearances similar to 
disease occurring in natural conditions, but that studies in 
which emulation of natural disease is needed should use 
methods as natural as possible, such as aerosol exposure with 
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p. haemolvtica. 
The unnatural production of disease by intratracheal 
inoculation of large numbers of organisms led scientists to 
attempt to produce pneumonic pasteurellosis by aerosol 
exposure of the respiratory tract with P. haemolytica. 
Saunders and Herman (1964) aerosol-exposed 6 calves to P. 
haemolytica after various stressors, with no significant 
responses occurring. Gilmour et al. (1975) inoculated 
colostrum-deprived lambs with approximately 1 X 10® CPU of P. 
haemolytica by aerosolization, with pneumonic lesions 
developing in only 4 out of 9 lambs. Frank (1979) stated 
that aerosol exposure of calves to P. haemolvtica either 
resulted in no reaction, or only a one-day febrile response. 
Panciera and Corstvet (1984) described a method of 
production of pneumonic pasteurellosis in which 2-5 ml of a 
P. haemolvtica inoculum was placed into the caudal lung lobes 
of cattle by transthoracic injection. This technique caused 
focal expanding pneumonia in 20 of 23 calves, with lesions up 
to 15 cm in diameter. The three remaining calves died of 
septicemia. This technique was subsequently used as a model 
of induction of pneumonic pasteurellosis in several studies 
evaluating protection by various immunization techniques 
(Confer et al.,1984, Confer et al., 1986b, Confer et al., 
1987) . 
Pneumonic pasteurellosis has been produced by 
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inoculation of calves with PI3 virus (Baldwin et al. 1967) or 
bovine herpesvirus 1 (BHV-1) (Jericho et al., 1976), followed 
by inoculation with P. haemolvtica. However, Frank (1979) 
summarized several studies reporting a range of clinical 
responses, from none to severe respiratory distress resulting 
from combined exposure of cattle to PI3 virus or BHV-l and P. 
haemolvtica. Studies in which viral agents are used in 
conjunction with P. haemolvtica are likely to have clinical, 
and possibly lung responses resulting from P. haemolvtica 
confounded with responses resulting from viral disease. 
Intravenous inoculation of calves with P. haemolvtica 
did not result in pneumonic lesions in two studies (Carter, 
1956, Horlein and Marsh, 1957). In a later study, however, 
Thomas et al. (1989) produced pneumonia in 5 of 5 calves that 
were inoculated intravenously with approximately 1 X 10® CFU 
of P. haemolvtica. 
Alternative pathogenesis of initiation of pneumonic 
pasteurellosis 
Because of the difficulty often encountered in 
reproducing pneumonic pasteurellosis by methods that mimic 
natural conditions, the study by Thomas et al. (1989) provided 
evidence that events involved in initiation of the disease 
may be misunderstood. It is generally accepted that 
initiation of pneumonic pasteurellosis begins with 
aerosolization of P. haemolvtica into the lung, a concept 
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that has been summarized by Frank (1979). Grey and Thomson 
(1971) proved that P. haemolvtica is present in the tracheal 
air of calves that have nasal passages colonized with the 
organism, and Jubb and Kennedy (1970) state that the 
pneumonic lesions start at the level of the respiratory 
bronchiole, suggesting that aerosolization of the organism is 
involved in initiation of pneumonia. 
Evidence to contradict the airway-route of initiation of 
pneumonic pasteurellosis was introduced when Thomas et al. 
(1989) described the production of pneumonic lesions in 
calves challenged intravenously with P. haemolvtica. In this 
study, calves inoculated intravenously with P. haemolvtica A1 
developed pneumonic lesions with distribution patterns and 
gross and microscopic lesions very similar to those occurring 
in natural cases of pneumonic pasteurellosis. Furthermore, 
Anderson et ai. (1991) isolated P. haemolytica from livers, 
spleens and mesenteric lymph nodes of cattle that were 
inoculated intrabronchially with P. haemolvtica. providing 
evidence of bacteremia. 
The ruminant tonsil is a possible site of invasion of P. 
haemolvtica. The sinus of the palatine tonsil of ruminants 
opens into the pharynx, where colonization of P. haemolvtica 
is likely to occur under certain conditions (Frank, 1992). 
During conditions of colonization of the nares and 
nasopharynx, Pasteurella hamolvtica might gain access into 
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the tonsil. Smith et al. (1983) demonstrated that cattle can 
generate carrier states where P. haemolvtica is present in 
the upper respiratory tract, yet elicit no humoral antibody 
response, which might allow long-term colonization of the 
tonsil. 
Pasteurella haemolvtica biotype A has been isolated from 
the tonsils of sheep under natural conditions (Al-Sultan and 
Aitken, 1985). After experimental infection of the palatine 
tonsils of calves with P. haemolvtica Al, the organism could 
be isolated from the tonsils for a duration of at least three 
weeks (Frank and Briggs, 1992). The authors of this study 
suggested that the bovine tonsil is a likely location where 
P. haemolvtica resides in healthy cattle. 
Once residing in the tonsil, P. haemolytica might invade 
the lymphoid tissue and gain access to the lung via the 
vascular system. Mycobacterium paratuberculosis (Momotani et 
al., 1988) and Brucella abortus (Ackermann et al., 1988) are 
endocytosed by the specialized follicle-associated epithelium 
of lymphoid tissue and transported to underlying phagocytic 
cells, allowing a probable portal of entry. Such a portal of 
entry has not been demonstrated for P. haemolvtica. however. 
Evidence of invasion of P. haemolvtica was demonstrated 
in a study where two of 12 calves that had P. haemolvtica 
inoculated into their tonsillar sinuses developed pneumonia 
(Frank et al., 1991). Calves also had swollen joints and 
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necrosis of retropharyngeal lymph nodes which was 
interpreted as evidence of invasion by P. haemolvtica. 
Although the above theory indicates that P. haemolvtica might 
invade the tonsil and gain access to the lung via the 
vascular system, it has not been proven. 
Protective immunity to Pasteurella haemolvtica 
Bacterins Vaccination studies of calves with P. 
haemolvtica bacterins were often reported as clinical studies 
(Amstutz et al.,1981, Handy and Trapp, 1964, Hamdy et al., 
1965), in which reduction of clinical signs of disease was 
not demonstrated. Palotay et al. (1963) vaccinated calves 
prior to weaning with several different P. haemolvtica 
bacterins, demonstrating significant reduction in morbidity 
in vaccinated calves after weaning, although the incidence of 
disease was almost 10% in the vaccinated calves. There was 
no mention of adjuvants used in any of the bacterins. 
Beneficial effects of vaccines demonstrated in field studies 
may be influenced by concurrent diseases other than 
pasteurellosis, and Panciera and Corstvet (1984) emphasized 
the value of models of disease to interpretable studies. 
Jericho et al. (1990) vaccinated calves twice 
intramuscularly with a formalin-killed P. haemolvtica 
bacterin with no adjuvant. Calves were later aerosol-
challenged with BHV-1 and P. haemolvtica. resulting in a mean 
percentage of pneumonic lung of 1.2% in vaccinated calves, 
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versus 25.2% in control calves. The authors of this study 
stated that it was the first report of protection afforded by 
a formalin inactivated, sonicated, adjuvant-free vaccine 
after challenge by BHV-1 and P. haemolvtica. 
Cardella et al. (1987) reported very little protection 
against P. haemolvtica challenge in calves vaccinated 
intramuscularly with £. haemolvtica - P. multocida bacterins 
adsorbed in aluminum hydroxide, while calves vaccinated with 
a bacterin incorporated into a mineral oil adjuvant had a 
high degree of protection after challenge. 
Vaccination of calves with formalin-killed P. 
haemolvtica in Freund's complete or incomplete adjuvant was 
associated with protection against experimental pneumonic 
pasteurellosis, whereas vaccination of calves with formalin-
killed £. haemolvtica in an aluminum hydroxide gel adjuvant 
did not protect calves against challenge (Confer et al., 
1987). 
Two studies of vaccination of calves with P. haemolvtica 
bacterins have reported detrimental effects after challenge 
with P. haemolvtica. Friend et al. (1977) reported that 
after challenge of calves vaccinated with a formalin-killed 
bacterin, serum antibody titers (direct bacterial whole cell 
agglutination, indirect bacterial agglutination, and passive 
hemagglutination) were positively correlated with the degree 
of pneumonic change, while nonvaccinated calves had antibody 
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titers that were negatively correlated with lung lesions. In 
this study, formalin-killed bacteria were administered in two 
doses, the first with Freund's complete adjuvant, the latter 
with Freund's incomplete adjuvant. Calves were also aerosol-
exposed to formalin-killed P. haemolvtica. 
Wilkie et al. (1980) demonstrated increased severity and 
rate of pneumonia in bacterin-vaccinated calves that were 
subsequently challenged with P. haemolvtica. Calves in this 
study were vaccinated subcutaneously one time with formalin-
treated P. haemolvtica emulsified in Freund's complete 
adjuvant. Subsequent serum antibody responses were generally 
low, but no correlations of antibody responses to lung 
lesions were made. The proposed reason for increased 
severity of pneumonia in calves in this study was that 
subcutaneous vaccination promoted production of opsonizing 
antibodies to P. haemolvtica. Opsonizing antibodies to P. 
haemolvtica had previously been associated with enhancement 
of P. haemolvtica-induced macrophage cytotoxicity (Wilkie & 
Markham,1979), presumably resulting in increased phagocytosis 
of organisms. Conversely, Newman et al. (1982) associated 
increased resistance to pneumonic pasteurellosis with greater 
uptake and degradation of bacteria by pulmonary phagocytes; 
greater uptake and degradation of P. haemolvtica should be 
dependent on opsonizing antibodies, which refutes the claim 
made by Wilkie et al. (1980) and Wilkie and Markham (1979). 
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The susceptibility of pulmonary phagocytes may be more 
dependent on the concentration of leukotoxin in the 
extracellular environment than on the degree of phagocyte 
uptake of £. haemolvtica. Leukotoxin has been demonstrated 
on the plasma membranes of bovine alveolar macrophages in 
pneumonic lungs of calves infected with P. haemolvtica 
(Whiteley et al., 1990), providing evidence that P. 
haemolvtica may not need to be phagocytosed prior to 
mediating leukotoxin-induced phagocyte injury, if sufficient 
leukotoxin was present in the extracellular environment. 
In summary of the protective effects of vaccination of 
calves with £. haemolvtica bacterins, disparate responses 
have been demonstrated, ranging from beneficial to 
detrimental effects. There also appears to be no 
consistently beneficial effect when adjuvants were used with 
the P. haemolvtica bacterins. 
Live vaccines Numerous studies have determined that 
subcutaneous vaccination of calves with live P. haemolvtica 
vaccines induces protection against challenge (Newman et al., 
1982, Kucera et al., 1983, Panciera et al., 1984, Catt et 
al., 1985, Corstvet et al., 1978, Confer et al. 1985a, Confer 
et al. 1986b). In one study, however, aerosol vaccination of 
calves with live P. haemolvtica did not result in protection 
against pneumonia after challenge with P. haemolvtica 
(Jericho and Langford, 1982). 
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Live vaccines may protect better than bacterins, at 
least in part because of induction of anti-leukotoxin 
antibodies by live vaccines (Wilkie et al., 1982). Since 
leukotoxin is produced only by actively growing P. 
haemolvtica (Shewen and Wilkie, 1985), sufficient in vivo 
replication of organisms in live vaccines may be necessary to 
induce a protective level of anti-leukotoxin antibodies 
(Confer et al., 1986b). Alternatively, since leukotoxin is 
elaborated into supernatants of P. haemolvtica cultures 
(Conlon et al., 1991), cell-free vaccines containing culture 
supernatant may serve to induce a protective level of anti-
leukotoxin antibodies. 
Component vaccines and protective antigens of 
Pasteurella haemolvtica Although live P. haemolvtica 
vaccines are generally associated with protection against 
pneumonic pasteurellosis that is superior to that associated 
with P. haemolvtica bacterins, undesirable responses 
indicative of P. haemolytica bacteremia and septicemia have 
been associated with vaccination of cattle with live P. 
haemolvtica vaccines (Zeman et al.,1990). Purification of 
antigenic components of P. haemolvtica that are associated 
with protection against pneumonic pasteurellosis would allow 
for effective immunization without the hazards of inoculation 
of potentially virulent live organisms. Several components 
of P. haemolvtica have been evaluated as immunizing agents 
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against pneumonic pasteurellosis, and cell-free vaccines have 
been commercially licensed. 
Matsumoto et al. (1984) vaccinated calves with a saline 
extract of P. haemolvtica. Calves vaccinated subcutaneously 
with the extract in aluminum hydroxide gel had only mild 
pneumonia after challenge with P. haemolvtica. while control 
calves had moderate to severe pneumonia. The nature of the 
extracted material was not identified, but McKinney et al. 
(1985) identified more than 15 proteins in a saline extract 
of P. haemolvtica. and suggested that the proteins could be 
from outer membranes of the cell wall or inner membrane, or 
internal proteins due to cell rupture. Confer et al. (1985b) 
vaccinated calves with a saline extract of P. haemolvtica in 
Freund's incomplete adjuvant, demonstrating protection by 
this method. After the challenge with P. haemolvtica. the 
vaccinated calves had a mean lesion score of 2.0, versus 13.8 
in control calves. The authors of this study suggested that 
the protective antigens in the extract may have been 
polysaccharide antigens from the capsule of the organism. 
In two studies, potassium thiocyanate (KSCN) was used to 
extract glycoproteins from P. haemolvtica. and the extracted 
glycoproteins were used as immunizing agents. Smith et al. 
(1983) determined that calves vaccinated with a KSCN extract 
developed serum antibodies to antigens in the extract. Yates 
et al. (1983) used a KSCN extract to vaccinate calves; 2/22 
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of the calves vaccinated subcutaneously or by aerosolization 
died after challenge with P. haemolvtica. while 7 of 14 
nonvaccinated control calves died after the challenge. 
A sodium salicylate extract of P. haemolytica was used 
to vaccinate calves in a study by Gilmour et al. (1987); 
vaccinated calves had more severe clinical responses and 
pneumonia than nonvaccinated calves after challenge with P. 
haemolvtica. 
Confer et al. (1989) demonstrated protection of calves 
against experimental challenge by vaccination with a 
carbohydrate-protein extract of P. haemolvtica. The extract 
was stated to be expected to contain capsular carbohydrates, 
outer membrane proteins, and low concentrations of LPS. High 
antibody responses to capsular carbohydrates were 
significantly correlated with low lung lesion scores after 
experimental challenge with P. haemolvtica. In a similar 
study, Townsend et al. (1987) demonstrated seroconversion to 
capsular carbohydrate of P. haemolvtica in calves vaccinated 
with live P. haemolytica or culture supernatants of P. 
haemolvtica. although the calves were not experimentally 
challenged in efforts to correlate the serum antibody 
response with protection against disease. 
Morton et al. (1990) reported that a sodium lauroyl 
sarcosinate insoluble preparation of P. haemolvtica. 
containing outer membrane proteins, was effective in 
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protecting calves against the transthoracic challenge with P. 
haemolvtica. Calves in this study were vaccinated twice with 
the outer membrane protein preparation combined with Freund's 
incomplete adjuvant. 
Several studies have associated high anti-leukotoxin 
antibodies with resistance to pneumonic pasteurellosis 
(Shewen and Wilkie, 1983b, Gentry et al., 1985, Confer et 
al., 1986b, Shewen and Wilkie, 1988). However, calves 
immunized with recombinant leukotoxin of P. haemolvtica A1 
were afforded no protective advantage to challenge with 
virulent P. haemolvtica (Conlon et al., 1991). In this study, 
however, calves were protected against experimental challenge 
after vaccination with a commercial P. haemolvtica vaccine 
enhanced with recombinant leukotoxin. The commercial vaccine 
used was a P. haemolvtica culture supernatant vaccine that 
confers anti-ieukotoxin immunity and immune responses to 
other soluble antigens present in the culture supernatant 
(Shewen et al., 1988). In the study by Conlon et al. (1991), 
however, calves vaccinated with the commercial vaccine alone 
had a lower, but not significantly lower degree of pneumonia 
than saline-treated controls. The authors of this study 
suggested, like Confer et al. (1987) and Shewen and Wilkie 
(1988) that although neutralizing antibodies to leukotoxin 
are very important in protection against pneumonic 
pasteurellosis, antigens related to the bacterial surface are 
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probably necessary to induce protective immunity. 
Cell-mediated immunity to Pasteurella haemolvtica 
Studies of bovine cell-mediated immunity (CMI) to P. 
haemolvtica have not been published. Maheswaran and Thies 
(1979) demonstrated CMI to P. multocida in calves, using a 
whole blood lymphocyte stimulation assay. Calves were 
vaccinated with P. multocida bacterins containing Freund's 
incomplete adjuvant, then venous blood cultures, prepared two 
to three weeks after vaccination, were stimulated with 
sonicated fractions of P. multocida. Stimulation indices of 
up to 5.2 were reported in vaccinated calves, however indices 
in nonvaccinated calves were not reported. 
Although certain humoral immune responses have been 
correlated with protection against pneumonic pasteurellosis 
(Confer et al., 1985a), CMI was not measured in the same 
study. It is possible that CMI was also contributing a major 
component to immune protection against P. haemolvtica. 
Confer et al. (1985a) reported that calves vaccinated with a 
live vaccine were protected from challenge with P. 
haemolvtica. while those vaccinated with a bacterin were not 
protected, even though antibody responses were not 
significantly different between the two groups. The authors 
suggested that a possible reason for the difference in 
protection coincident with no difference in antibody response 
may have been due to cell-mediated immune responses in the 
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calves vaccinated with a live vaccine. 
Wells et al. (1979) compared lymphocyte proliferative 
responses to P. haemolvtica antigens in a group of passively 
immunized lambs and a group of lambs vaccinated with an 
aluminum hydroxide adsorbed sodium salicylate extract of P. 
haemolvtica. Lymphocyte proliferative responses were present 
only in actively immunized lambs, which were protected 
against subsequent challenge with P. haemolvtica. while 
passively immunized lambs were not protected. This study 
provided evidence that CMI may be more important than humoral 
immunity in protection against pneumonic pasteurellosis. 
Although lymphocyte proliferative assays are commonly 
used to evaluate CMI responses (Schultz, 1982), in vitro 
measurement of CMI responses may also be accomplished by 
measurement of specific cytokines that are elaborated in 
antigen-specific T lymphocyte responses, such as gamma 
interferon. Gamma interferon is produced only by antigen 
activated T lymphocytes (DeMaeyer and DeMaeyer-Guignard, 
1992) . 
As an effector cytokine of the CMI response, gamma 
interferon may provide additional assistance in elimination 
of P. haemolvtica by enhancing phagocyte uptake and killing 
of organisms. Gamma interferon has been shown to enhance 
cellular antimicrobial activities against several bacterial 
organisms, including Mycobacterium bovis (Flesch and 
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Kaufmann, 1988) and Listeria monocytogenes (Portnoy et al., 
1989). Administration of gamma-interferon to mice has been 
shown to reduce infection rates after challenge with Brucella 
abortus (Stevens et al., 1992) and administration of gamma 
interferon to dexamethasone-immunosuppressed calves prior to 
challenge with Haemophilus somnus reduced the subsequent 
severity of pneumonia (Chiang et al., 1990) 
Mice that were aerosol-infected with Bordetella 
pertussis developed in vitro lymphocyte proliferative 
responses to B. pertussis antigens at a simultaneous time 
period as in vitro gamma interferon responses. The time 
period of induction of these CMI responses coincided with 
clearance of B. pertussis from the lung, whereas induction of 
antibody responses occurred only when the infection was 
almost cleared. The authors of the study concluded that the 
CMI response was more important in clearance of organisms 
than the humoral response (Petersen et al., 1992). Although 
B. pertussis is generally considered to exist in the 
extracellular environment, it has been demonstrated to 
survive intracellularly in macrophages (Saukkonenet et al., 
1991). 
The potential beneficial effects of CMI against P. 
haemolvtica are unknown. Pasteurella haemolvtica survives 
and replicates in the extracellular environment (Confer et 
al., 1988), while studies of CMI responses have generally 
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involved intracellular organisms. Cell-mediated immune 
responses, however, would be expected to aid humoral immune 
responses in bactericidal activities against £. haemolvtica. 
especially during and after phagocyte uptake of the organism. 
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AND INTRATONSILLAR ROUTES OF INOCULATION 
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Factors involved in induction of bovine pneumonic 
pasteurellosis are poorly defined, and production of 
pneumonia by intratracheal inoculation of the causative 
agent, Pasteurella haemolvtica is inconsistent (Yates, 1982). 
The organism is thought to gain access to the lung via the 
airways, originating from the nasopharynx which has been 
heavily colonized (Grey and Thompson, 1971) . However, there 
are no reports of reproduction of the disease after 
inoculation of P. haemolvtica directly into the nasal cavity 
of normal cattle. 
Pneumonic pasteurellosis can be induced by intravenous 
inoculation of P. haemolvtica biotype A serotype 1 (Al) 
(Thomas et al., 1989). Calves inoculated intravenously with 
this biotype developed pneumonic lesions with distribution 
patterns and gross and microscopic lesions very similar to 
those seen in natural cases of the disease. Also, P. 
haemolvtica has been isolated from livers, spleens and 
mesenteric lymph nodes of cattle inoculated intrabronchially 
with Pi. haemolvtica. suggesting that bacteremia had occurred 
(Anderson et al., 1991). 
Goats are susceptible to pneumonic pasteurellosis under 
natural conditions (Young and Griffith, 1985). Pasteurella 
haemolvtica has been isolated from the nasal cavity of goats, 
increased populations being associated with stressful 
29 
conditions (Jasni et al., 1991), as in cattle (Frank and 
Smith, 1983). This suggests that the goat can serve as a 
model for bovine pneumonic pasteurellosis. 
Tonsils often serve as a reservoir for infectious 
agents, and lymphoid tissues are a site of entry for a number 
of pathogens (Woode et al., 1984, Ackermann et al., 1988, 
Momotani et al., 1988). Pasteurella haemolvtica biotype A 
has been isolated from the tonsils of cattle and sheep (Al-
Sultan and Aitken, 1985, Frank and Briggs, 1991), but it is 
not known whether it may invade the tonsils of ruminants and 
produce systemic disease. 
The objectives of this study were to evaluate 
intratracheal, intravenous and intratonsillar routes of 
inoculation of P. haemolvtica A1 in goats, and to 
characterize any lesions that developed after inoculation. 
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MATERIALS AND METHODS^ 
Animals 
Ten colostrum-deprived, crossbred goats were reared in 
isolation until they were 14-18 weeks of age. Antibody 
levels to P. haemolvtica. as determined by indirect 
hemagglutination (Frank and Smith, 1983), ranged from 1:4 to 
1:16 in 7 goats. Pasteurella haemolvtica was not isolated 
from nasal swabs prior to inoculation. Goats were randomly 
assigned to 3 treatment groups (3 goats per group) with one 
remaining as a sham inoculated control. Goats were 
inoculated with P. haemolvtica A1 (isolate LlOl) that was 
isolated from pneumonic bovine lung. Goats inoculated 
intratracheally and intravenously were given 10 ml of an 
inoculum containing 2.0 X 10® CFU, while those inoculated 
intratonsillarly were given 0.1 ml of an inoculum containing 
2.3 X 10^ CFU, which was placed into the palatine tonsillar 
sinus. The control goat was inoculated with 10 ml of sterile 
tryptose broth intratracheally and intravenously, and 0.1 ml 
intratonsillarly. 
Goats were killed and necropsied 42-66 hours after 
inoculation and tissue samples were collected for 
quantitative bacterial culture and for histopathology. 
^A more detailed description of materials and methods is 
presented in Appendix 3. 
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RESULTS 
All goats inoculated intratracheally had pulmonary 
lesions which consisted of consolidation of the ventral 
portions of the anterior and middle lobes. One of these 3 
goats had a 5 cm raised focus of consolidation and hemorrhage 
in the caudal lobe that was overlain with pleural fibrin 
deposits. Approximately 11, 15, and 22% of the total lung 
volume was consolidated in each of these goats. 
One of the goats inoculated intravenously had gross 
pulmonary lesions. Anterior lobes and the middle lobe of this 
goat had consolidation of the ventral portions, in addition 
to a 6 cm diameter focus in the right caudal lobe. 
Approximately 17 % of the lung volume of this goat was 
consolidated. A thick fibrinous exudate covered the middle 
lung lobe, and extended ventrally over the mediastinal 
surface. 
No gross lesions were present in the lungs or tonsils of 
the goats that were inoculated intratonsillarly, nor were 
significant gross lesions present in other tissues of any 
goats. No gross lesions were present in the sham-inoculated 
goat. 
Histopatholoaical findings 
The lung lesions in the transtracheally inoculated goats 
consisted of extensive areas of fibrinosuppurative to 
necrotizing bronchopneumonia. The alveolar spaces were 
32 
filled with serofibrinous fluid and leukocytes, primarily 
neutrophils with fewer macrophages. Multifocally, 
bronchioles contained similar exudates, and interlobular 
septa were widened by deposition of fibrin and edema. 
Alveolar septa had increased numbers of type II pneumocytes. 
Subpleural hemorrhage and infiltrates of low numbers of 
neutrophils into the pleura were multifocally present. 
The lung lesions in the intravenously inoculated goat 
were similar to those in the transtracheally inoculated 
animals. Differences consisted of increased type II 
pneumocyte hyperplasia and increased severity of fibrinous 
pleuritis in the intravenously inoculated goat. There were 
areas where a layer of fibrin up to 50 micrometers thick was 
present on the pleural surface of the lung. Pleuritis in the 
intravenously inoculated goat was often seen over 
unconsolidated lung parenchyma, but pleuritis in the 
transtracheally inoculated goats was typically over 
consolidated lung. 
No microscopic lesions were present in the lungs from 
the intratonsillarly inoculated goats, or in other tissues 
from inoculated goats. There were no microscopic lesions 
present in tissues from the sham inoculated control goat. 
Microbiological findings 
Of the goats inoculated intravenously, P. haemolvtica 
was isolated from blood samples taken at 1 min after 
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inoculation (330, 240, and 180 CFU/ml respectively). No 
bacteria were isolated from other blood samples. 
Pasteurella haemolvtica A1 was isolated from the tonsils 
of all 3 intratonsillarly inoculated goats at 7 X 10^, 2 X 
10®, and 5 X 10® CFU/g of tonsil, respectively. Four X 10^ 
CFU/g of tissue were isolated from a lung lesion of one goat 
inoculated transtracheally. Pasteurella spp. were not 
isolated from the lungs of other goats, nor from any other 
tissues of remaining goats. 
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DISCUSSION 
Inoculation of goats by the transtracheal route resulted 
in pneumonia in 3 of 3 goats, indicating that the goat may 
serve as a suitable model for studies of bovine pneumonic 
pasteurellosis. 
As P. haemolvtica A1 was isolated from blood only 
immediately after intravenous inoculation, bacteria were 
apparently rapidly cleared by fixed tissue macrophages or 
rapidly killed or altered by serum-associated bacteriolytic 
factors. 
The lack of isolation of P. haemolvtica from the 
pneumonic lung in 3 of the 4 goats in this study, may have 
been due to effective host responses in eliminating viable 
organisms by the time of necropsy. The body temperatures had 
declined by then, also suggesting a reduction in the 
inflammatory processes associated with the elimination of 
viable P. haemolvtica from the pneumonic foci. 
Intravenous inoculation of goats in the present study 
resulted in less consistent production of pneumonia and a 
lesser amount of pulmonary involvement than in the study by 
Thomas et al. (1989), in which 5 of 5 calves had pneumonic 
lesions with 14% to 46% (mean 28%) of the pulmonary 
parenchyma being consolidated after intravenous inoculation 
of calves with approximately 1 X 10® CFU of P. haemolvtica 
Al. The lesser rate and degree of pneumonia in the present 
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study may have been associated with the lower number of 
organisms used. In the study by Thomas et al. (1989), the 
organisms were apparently inoculated with accompanying 
culture supernatant, and calves may have been given large 
amounts of endotoxin, leukotoxin, and/or other bacterial 
components that could alter normal host defenses against 
blood borne pathogens. 
There was no evidence of invasion of P. haemolvtica A1 
via the palatine tonsil after inoculation, even though 3 of 3 
goats inoculated intratonsillarly had tonsils colonized by 
the organism. This suggests that this isolate of P. 
haemolvtica failed to invade, or, if invasion occurred, 
intravascular phagocytosis eliminated organisms without 
formation of lesions. Other host factors such as 
environmental stress may enhance invasion by certain 
bacteria, and such stressors or similar factors may have been 
lacking in this study. 
The establishment of pneumonic lesions after intravenous 
inoculation of bacterial organisms implies that large numbers 
of bacteria are deposited in the lung. Ruminant lungs 
possess pulmonary intravascular macrophages which are 
responsible for the clearance of most intravascular 
bacteria, whereas some species of animals (such as the rat) 
that lack pulmonary intravascular macrophages have clearance 
of intravascular organisms primarily in the spleen and liver 
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(Warner et al., 1987). Therefore, the lung may be a target 
of deposition of bacteria following intravenous inoculation 
in ruminants. However, Thomas et al. (1989) state that 
inoculation of other Gram-negative bacteria into cattle does 
not result in replication of bacteria in the lung as does 
inoculation with P. haemolvtica. indicating that there are 
other factors involved in predilection of P. haemolvtica to 
pulmonary tissue in cattle. 
The low antibody titers to P. haemolytica in the goats 
indicates probable exposure to the organism even though they 
were raised in isolation. How low levels of antibody may 
have affected the outcome of this study is unknown, although 
it has been shown that calves vaccinated with P. haemolvtica 
bacterins may have more severe disease than non-vaccinates 
(Wilkie et al., 1980). Of interest is the fact that the goat 
in this study with the most lung consolidation also had the 
highest antibody titer to P. haemolvtica. No other 
correlations between serum antibody level and degree of 
pneumonia could be drawn. 
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Cell-mediated immune mechanisms may play a role in the 
pathogenesis and prevention of pneumonia in cattle that is 
caused by Pasteurella haemolvtica serotype Al. The 
circumstances required to stimulate and identify cell-
mediated immune mechanisms were determined in calves. Calves 
were vaccinated with a commercial P. haemolvtica bacterin or 
a live commercial P. haemolvtica vaccine, or were infected 
intratracheally with virulent P. haemolvtica. All calves 
were challenge-exposed intratracheally with P. haemolvtica 31 
days after vaccination or infection. Peripheral blood 
mononuclear cells and mediastinal and superficial cervical 
lymph node cells were stimulated with antigens prepared from 
P. haemolvtica to evaluate in vitro proliferative responses 
and gamma interferon production as measures of cell-mediated 
immunity. Strong proliferative responses and gamma 
interferon production were detected in lymph node cells from 
calves vaccinated with the live vaccine and infected calves, 
in response to stimulation with an outer membrane protein 
preparation from P. haemolvtica. Greater proliferative 
responses and gamma interferon production were associated 
with the lymph node nearer the site of bacterin 
administration (superficial cervical lymph node) or the site 
of infection (mediastinal lymph node), whereas greater 
proliferative responses and gamma interferon production were 
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associated with the more distant lymph node (mediastinal 
lymph node) in calves vaccinated with the live vaccine. 
Neither proliferative responses nor gamma interferon 
production were detected in peripheral blood mononuclear 
cells from calves that were vaccinated for or infected with 
P. haemolvtica. Protection against pneumonic lesions was 
more closely correlated with antibody responses than with 
proliferative or gamma interferon responses. 
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INTRODUCTION 
Pasteurella haemolvtica biotype A serotype 1 causes 
severe pneumonia in cattle. Numerous experimental and 
commercial vaccines, including killed bacterins and live 
vaccines have been developed for immunization of cattle 
against P. haemolvtica. Generally, immunization with P. 
haemolvtica bacterins provides poor protection of cattle 
against natural or experimental disease (2, 20, 21) and has 
even been associated with enhancement of experimental and 
natural disease (16, 33). Immunization of calves with 
bacterins in Freund's adjuvant (7), or live £. haemolvtica 
(5, 6, 10, 25), however, has been demonstrated to provide 
protection against challenge. 
Pasteurella haemolvtica produces a potent leukotoxin 
that is inhibitory or lethal to bovine neutrophils, 
mononuclear phagocytes, and lymphocytes (11, 12, 22). 
Investigators have attributed the protection afforded by live 
vaccines to their induction of leukotoxin-neutralizing 
antibodies (18). Calves protected against P. haemolvtica 
challenge by immunization with a bacterin in Freund's 
adjuvant, however, did not produce leukotoxin-neutralizing 
antibodies, indicating that antibodies to components other 
than leukotoxin can afford protection (7). Subsequently, it 
was demonstrated that immunization of calves with recombinant 
bovine leukotoxin did not result in protective immunity (9), 
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indicating that effective humoral immune protection probably 
requires antibody responses to somatic antigens of P. 
haemolvtica in addition to anti-leukotoxin antibodies. 
Humoral immune mechanisms are thought to be important in 
the defense against pneumonic pasteurellosis. Pasteurella 
haemolvtica is killed after incubation with antiserum as a 
result of complement-mediated killing (23), and opsonization 
of P. haemolvtica enhances phagocyte ingestion of the 
organism (24) . However, protection against pneumonic 
pasteurellosis does not always correlate with antibody 
titers. Confer et al. (6o) immunized cattle with killed or 
live P. haemolvtica. and both groups developed similar serum 
antibody titers. The cattle immunized with live organisms 
were more resistant to challenge with virulent organisms than 
those immunized with killed organisms, leading the authors to 
suggest that the enhanced resistance may have resulted from 
the ability of live organisms to stimulate stronger cell-
mediated immune (CMI) responses than killed organisms, even 
though antibody responses were not significantly different. 
There is additional evidence that CMI may be important 
in protection against pneumonic pasteurellosis. Wells, et 
al. (32) demonstrated that lambs that were passively 
immunized with P. haemolvtica antiserum were not protected 
from disease after challenge with P. haemolvtica. whereas 
lambs immunized with a sodium salicylate extract were 
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resistant to challenge, even though antibody titers were not 
significantly different between the two groups. A CMI 
response was detected only in the lambs that were actively 
immunized, which may have been an important protective factor 
against the P. haemolvtica challenge. 
The purpose of this study was to identify CMI responses 
of cattle to £. haemolvtica. as well as identify P. 
haemolvtica antigens that can be used to identify this 
response. Calves infected with P. haemolvtica and calves 
vaccinated with a live or killed P. haemolvtica vaccine were 
used to evaluate CMI responses to P. haemolvtica. Peripheral 
blood mononuclear cells (PBMC) and lymph node cells were 
harvested and stimulated with 5 antigen preparations from P. 
haemolvtica. Lymphocyte proliferative responses and gamma 
interferon production were used as measures of CMI. 
To assess the role of CMI versus humoral immunity as 
protective factors against pneumonic pasteurellosis, all 
calves were challenge-exposed to P. haemolvtica. and lung 
lesions and bacterial concentrations in lung tissues were 
assessed for correlation with CMI and antibody responses. 
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MATERIALS AND METHODS 
Bacterial culture 
Pasteurella haemolvtica biotype A serotype 1 (strain 
LlOl, kindly provided by G. H. Frank, Ames, lA) was isolated 
on blood agar from a pneumonic bovine lung. Eight isolated 
colonies were inoculated into tryptose broth and incubated at 
37 C for 6 hours, aliquoted into vials, and stored at -70 C 
until used for antigen preparations or inoculations. 
Antigen preparation 
Capsular polysaccharide (CP), lipopolysaccharide (LPS), 
lipopolysaccharide-associated protein (LAP), and a bacterial 
cell sonicate (SON) were prepared from P. haemolvtica strain 
LlOl to use as antigens to stimulate PBMC and lymph node cell 
cultures. An outer membrane protein preparation (OMP) of P. 
haemolvtica serotype 1 was kindly provided by A. W. Confer, 
Stillwater, OK, prepared as previously described (28). 
Strain LlOl was grown on dextrose starch agar for 24 
hours at 37 C, and harvested in distilled water. Bacteria 
were pelleted by centrifugation and the supernatant was 
saved. Cells were dehydrated in 50% ethanol, washed twice in 
acetone, twice in ethyl ether, and then air-dried. 
The supernatant was placed in dialysis bags (12-14,500 
nominal mol. wt. cutoff. Spectrum Medical Industries, Inc., 
Los Angeles, CA) and covered for 18 hours with 
carboxymethylcellulose (Aquacide I, Calbiochem Corp, La 
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Jolla, CA). The CP was extracted from the concentrated 
culture supernatant as previously described (1). Alpha-
amylase, (Sigma Chemical Co., St Louis, MO) 500 U/ml, was 
added and the mixture was incubated for 2 hours at 37 C and 
18 hours at 4 C to remove residual starch derived from the 
growth medium. The CP was precipitated with ethanol and 
sodium acetate, and resuspended in a buffer (pH 7.2) 
containing 10 mM Tris, 145 mM NaCl, 0.2% SDS and 500 ug (16 
U)/ml proteinase K (Amresco, Solon, OH). The suspension was 
heated at 60 C for 2 hours then 18 hours at 37 C. The 
suspension was recycled for 1 hour over an endotoxin-removing 
affinity column (Detoxi-gel, Pierce, Rockford, IL). The CP 
was again precipitated with ethanol and sodium acetate, 
resuspended in pyrogen-free distilled water (Baxter 
Healthcare Corp, Deerfield, XL), precipitated and resuspended 
again, and lyophilized. The CP, which contained less than 
0.25% protein and O.Ol % LPS, was reconstituted in Hanks 
balanced salt solution (HBSS) (Gibco Laboratories, Long 
Island, NY) and stored at -20 C. 
Lipopolysaccharide was extracted from dried cells with a 
phenol, chloroform, and petroleum ether solution, as 
previously described (17). The LPS was resuspended in 
distilled water, heated at 56 C for 30 min, lyophylized, 
resuspended in a buffer (pH 7.2) containing 10 mM Tris, 145 
mM NaCl, 0.2% SDS and 500 ug (16U)/ml proteinase K. The 
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suspension was heated for 2 hours at 60 C, then was incubated 
for 18 hours at 37 C. The LPS was precipitated from the 
buffer with ethanol and sodium acetate, and the precipitate 
was resuspended in pyrogen-free distilled water. The LPS was 
precipitated again in ethyl alcohol and sodium acetate, 
resuspended in pyrogen-free distilled water, and lyophilized. 
The LPS, which contained approximately 0.7% protein (3), was 
resuspended in HBSS at 0.4 mg/ml and stored at -20 C. 
Lipopolysaccharide-associated protein was extracted from 
the phenol supernatant of the LPS extraction as previously 
described (30). Extracted LAP was washed 3 times with 
ethanol, 3 times with ethyl ether, dried, reconstituted in 
pyrogen-free distilled water, and lyophilized. The LAP 
contained 0.02% LPS as determined by a chromogenic limulus 
amebocyte assay (QCL-1000, Whittaker Bioproducts, 
Walkersville, MD). 
A bacterial cell sonicate was prepared by collecting P. 
haemolvtica cells from 18 hours of growth on sheep blood agar 
plates that were incubated at 37 C. Cells were collected in 
distilled water and sonicated on ice with an ultrasonic cell 
disrupter (Microson, Heat Systems Ultrasonics, Farmingdale, 
N.Y.) for 1 min at the maximum power setting. The 
preparation was centrifuged at 5900 X g for 20 min., and the 
supernatant was filtered through a 0.22 micrometer filter, 




Twelve 3-7 month-old, colostrum-deprived, male Holstein 
and Holstein crossbred calves were housed in isolation barns 
in American Association for Accreditation of Laboratory 
Animal Care (AAALAC) accredited facilities. Calves were fed 
a complete pelleted ration twice daily, and water was 
available ad libitum. 
Vaccination and infection of calves 
Calves were divided into 4 groups of 3 calves, and were 
vaccinated or infected with P. haemolvtica on day 0. Calves 
of one group (bacterin group) were vaccinated with a 
Pasteurella haemolvtica-Pasteurella multocida bacterin 
fPasteurella haemolvtica-Pasteurella multocida bacterin. Lot 
No. 923, Colorado Serum Co., Denver, CO). Calves in a second 
group (live vaccine group) were vaccinated with a live P. 
haemolvtica vaccine (Respirvac, Lot No. 7671, Beecham 
Laboratories, Bristol, TN). Vaccines were administered in 
the subcutis of the left cervical area. Calves in a third 
group (convalescent group) were intratracheally infected with 
10 ml of an inoculum containing 3.0 X 10® CPU of P. 
haemolvtica strain LlOl. The inoculum was prepared by 
inoculating 1 ml of aliquotted strain LlOl into 30 ml of 
tryptose broth and incubating at 37 C for 3 hours. Bacteria 
were pelleted by centrifugation at 5900 X g for 5 min., 
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resuspended in tryptose broth to 80% transmittance at 600 nm 
wavelength (Coleman Jr. Model 35 spectrophotometer, Bacharach 
Instrument Co., Pittsburgh, PA), then further diluted in 
tryptose broth to approximately 1 X 10® CFU/ml for 
inoculation of calves. Bacterial concentration was verified 
by plate counts. Calves in the convalescent group were 
treated with antibiotics (Gentocin, 2 mg/kg intramuscularly. 
Sobering Corp., Kenilworth, N. J., and Naxcel, 2 mg/kg, 
intramuscularly, Upjohn Co., Kalamazoo, MI) on days 3-6 to 
reduce the morbidity following infection with P. haemolvtica. 
A fourth group (unvaccinated group) consisted of calves that 
received no exposure to P. haemolvtica. Body temperatures of 
all calves were monitored daily for 3 days after initial 
vaccination or infection. Calves in the bacterin group were 
re-vaccinated on day 15 of the experiment. 
Antibody titers 
Serum samples were collected from all calves on days 1, 
4, 8, 11, 15, 18, 22, 25 and 31 for determination of antibody 
titers to P. haemolvtica strain LlOl, by an indirect 
hemagglutination assay (15). Serum antibody titers were 
converted to logg prior to statistical analyses, with a mean 
of 0.6 on day 0. 
Lvmphocvte proliferation assavs 
Blood was collected from calves on days 1, 4, 11, 15, 
18, 22, and 25 for isolation of PBMC for lymphocyte 
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proliferation assays. Fifty ml of venous blood was collected 
into 5 ml of acid citrate dextrose, centrifuged at 600 X g 
for 25 min, and buffy coats were collected. Erythrocytes in 
buffy coats were lysed with phosphate buffered water, 
followed by restoration of osmolarity with hypertonic 
phosphate buffered saline. Peripheral blood mononuclear 
cells were washed twice in HBSS, and resuspended in complete 
medium composed of RPMI 1640 (Gibco Laboratories, Long 
Island, NY) supplemented with 25 mM L-glutamine, 5 X 10~® M 
2-mercaptoethanol, 200 lU penicillin/ml, 200 ug 
streptomycin/ml, 0.5 ug amphotericin B/ml, and 10% bovine 
fetal serum (Hy-Clone Laboratories, Logan, UT). Two-hundred 
ul of complete media containing 2 X 10® PBMC were delivered 
to each well of flat-bottom microtiter plates. Antigens (CP, 
LPS, LAP, and OMP), in 25 ul of RPMI, were added to wells in 
triplicate at concentrations of 1.0 and 0.1 ug/well. The 
SON antigen was added at 0.1 and 0.01 ug/well. Cell 
cultures were incubated for 52-54 hours at 37 C in a 
humidified atmosphere with 5% COg, and pulse-labelled with 
H^-thymidine (Amersham Corp, Arlington Heights, IL) at 0.4 
uCi/well. Cells were incubated an additional 18-20 hours, 
harvested onto fiberglass filters, and radioactivity was 
measured by liquid scintillation counting. Counts per minute 
(CPM) of background wells (no antigen) were subtracted from 
CPM of antigen-stimulated wells, and the difference was 
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designated difference in counts per minute (DCPM). 
For lymph node cell assays, lymph nodes were minced and 
cells were passed through #60 mesh stainless steel screens. 
Lymphocytes were isolated using Histopaque 1083 (Sigma 
Chemical Co., St. Louis, MO), washed twice in 0.1 M 
phosphate-buffered saline, pH 7.2, and resuspended at 2 X 10^ 
cells/ml in complete media. Lymph node cell preparations 
were thereafter treated in the same manner as PBMC 
preparations. 
Gamma interferon assays 
Peripheral blood mononuclear cell and lymph node cell 
suspensions were added to plates and stimulated with antigens 
in the identical manner as that used for the lymphocyte 
proliferation assays. After 46-48 hours incubation, plates 
were centrifuged at 100 X g for 5 min, and supernatants were 
collected and immediately frozen and stored at -20 C. 
Gamma interferon was measured using a commercial ELISA 
kit (Mycobacterium paratuberculosis gamma-interferon test 
kit, IDEXX Laboratories, Westbrook, ME), with modifications. 
Culture supernatants were substituted for plasma samples, and 
recombinant gamma interferon (supplied by IDEXX Laboratories) 
was used as a standard for quantitative determinations. 
Supernatants from PBMC cultures from days 4, 11, and 18 that 
were stimulated with OMP at 0.1 ug/well and supernatants from 
lymph node cell cultures that were stimulated with OMP at 0.1 
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ug/well were analyzed for gamma interferon. Gamma interferon 
concentrations in supernatants of background wells were 
subtracted from those of supernatants of antigen-stimulated 
wells and the difference was designated difference in 
interferon (DIFN). 
Challenge and necropsv 
On day 31 of the experiment, all 12 calves were 
challenge-exposed intratracheally to 10 ml of inoculum 
containing 2.0 X 10® CPU of P. haemolvtica. Body 
temperatures were monitored daily for 3 days after the 
challenge-exposure. Calves were euthanatized and necropsied 
on days 35 (6 calves) and 36 (5 calves). One calf from the 
unvaccinated group died on day 33 with severe pneumonic 
lesions as a result of the challenge. 
The caudal mediastinal and superficial cervical lymph 
node (ipsilateral to site of vaccination) were removed at 
necropsy for lymph node cell preparations in the lymphocyte 
proliferation and gamma interferon assays. 
The volume of acute pneumonic parenchyma was estimated 
for each calf and recorded as % pneumonia. Sections of lung 
were fixed in 10% neutral buffered formalin for 
histopathology. Lung sections were processed and embedded by 
routine paraffin techniques, sectioned, and stained with 
hematoxylin and eosin by standard methods. 
A section of pneumonic lung was collected from each 
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animal for quantitative bacterial culture, and the CFU of P. 
haemolvtica/g of lung were converted to log^g prior to 
statistical analyses. 
Statistical analyses 
Analysis of variance (SAS Institute Inc., Gary, N.C.) 
was used to determine significant differences between group 
means for DCPM, DIFN, antibody titer, body temperature, % 
pneumonia, and CFU of P. haemolvtica/a of lung. When the 
overall F test was significant (P<0.05), t tests (LSD) were 
used to determine specific differences between group means 
(P<0.05). Linear regression analysis of serum antibody titer 
on day 31, DIFN and DCPM from mediastinal lymph node cells 
stimulated with OMP at 0.1 ug/well versus % pneumonia and CFU 
of P. haemolvtica/a of lung were used to correlate immune 
responses to the severity of pulmonary disease. Correlation 
coefficients were also determined for DIFN versus DCPM (from 
mediastinal lymph node cells stimulated with OMP at 0.1 
ug/well) to correlate gamma interferon responses with 
proliferative responses, and DCPM and DIFN from mediastinal 
lymph node cells stimulated with OMP at 0.1 ug/well were 
correlated with serum antibody response on day 31 to 




Clinical responses of calves 
By 20 hr after vaccination or infection, calves in the 
live vaccine and convalescent group had significantly 
elevated body temperatures (P<0.05) over calves in the 
unvaccinated group. Body temperatures in these two groups 
remained elevated until approximately 96 hours after 
vaccination or infection. All three calves in the live 
vaccine group developed extensive swelling at the site of 
vaccination, which extended ventrally to the sternum in one 
calf. 
Calves in the convalescent group had clinical evidence 
of pneumonia after infection on day 0, which included 
hyperpnea, anorexia, and coughing. However, signs subsided 
by day 5. 
Antibody responses 
Serum antibody titers peaked for the live vaccine and 
convalescent group between days 8 and 11 (Fig. 1). Calves in 
the bacterin group, which were re-vaccinated on day 15, had a 
maximum mean antibody titer on day 22. On day 11, mean 
antibody titers of the bacterin, live vaccine and 
convalescent groups were significantly greater than that of 
the unvaccinated group (P<0.05), while the mean titers of the 
live vaccine and convalescent groups were also greater than 
that of the bacterin group. There were no significant 
Fig. 1. Mean serum antibody titers of calves by experimental 
group as determined by an indirect hemagglutination 
assay. Calves were vaccinated or infected with P. 
haemolvtica on day 0, and calves in the bacterin 
group were re-vaccinated on day 15. There is a 
significant difference (P<0.05) between group means 
within a day when a common letter is not present. 















differences (P=0.07) between any of the group mean antibody 
titers on day 31. 
Proliferative responses 
Proliferative responses (DCPM) for PBMC and lymph node 
cells stimulated with CP, LPS, and LAP were unremarkable when 
compared to background wells, with DCPM generally below 2 X 
10^ CPM. Differences between experimental groups were not 
present in mean DCPM of PBMC or lymph node cells stimulated 
with CP, LPS, or LAP. Additionally, there were no 
significant experimental group differences for the mean DCPM 
of PBMC stimulated with OMP or SON antigens at any time 
period. The DCPM for PBMC stimulated with OMP or SON were 
also generally below 2 X 10^ CPM (data not shown). 
Lymph node cells stimulated with OMP at 0.1 ug/well had 
higher DCPM than those stimulated with OMP at 0.01 ug/well, 
and those stimulated with SON at 0.01 ug/well had higher DCPM 
than those stimulated with SON at 0.1 ug/well. Therefore, 
all reported responses are from cells stimulated with OMP at 
0.1 ug/well and SON at 0.01 ug/well. 
The DCPM of mediastinal lymph node cells from the 
convalescent group that were stimulated with OMP was 
significantly higher than the DCPM from mediastinal lymph 
node cells from the unvaccinated, bacterin, or live vaccine 
group when stimulated with OMP (P<0.02) (Fig. 2). 
Significant differences between experimental groups were not 
Fig. 2. Proliferative responses of superficial cervical and 
mediastinal lymph node cells stimulated with outer 
membrane protein (OMP) from P. haemolvtica. Calves 
were vaccinated or infected with P. haemolvtica 35 
or 36 days prior to stimulation of lymph node cells. 
Values represent mean DCPM (difference of CPM of 
antigen-stimulated wells and CPM of background 
wells) by experimental group. There is a 
significant difference (P<0.05) between the 
experimental group means within a lymph node when a 
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present in the DCPM of superficial cervical lymph node cells 
stimulated with OMP (P>0.05). 
A significant difference in DCPM between superficial 
cervical and mediastinal lymph node cells within experimental 
groups was present in OMP-stimulated cells (P<0.02) (Fig. 2). 
Calves in the bacterin group had a higher DCPM in superficial 
cervical than in mediastinal lymph node cells, while calves 
in the live vaccine and convalescent groups had a higher DCPM 
in mediastinal than in superficial cervical lymph node cells. 
When the DCPM were averaged over superficial cervical 
and mediastinal lymph nodes cells stimulated with OMP, 
differences between experimental groups were present (P<0.03) 
(Fig. 3). The live vaccine and convalescent group had a 
significantly higher DCPM than the unvaccinated group, while 
the DCPM of the convalescent group was also significantly 
higher than that of the bacterin group. 
Differences between experimental groups were present in 
proliferative responses of mediastinal lymph node cells 
stimulated with SON (P<0.02), with the convalescent group 
having a significantly higher DCPM than the unvaccinated, 
bacterin, or live vaccine group (data not shown). A 
significant difference in DCPM between superficial cervical 
and mediastinal lymph node cells within experimental groups 
was present in SON-stimulated cells (P<0.05). Calves in the 
bacterin group had a higher DCPM in superficial cervical than 
Fig. 3. Proliferative and gamma interferon responses 
averaged over superficial cervical and mediastinal 
lymph node cells stimulated with outer membrane 
protein (OMP) from P. haemolvtica. Calves were 
vaccinated or infected with P. haemolvtica 35 or 36 
days prior to stimulation of lymph node cells. The 
values represent mean DCPM or DIFN (difference of 
CPM or ng/ml of gamma interferon of antigen-
stimulated wells from background wells) by 
experimental group, averaged over the superficial 
cervical and mediastinal lymph nodes. There is a 
significant difference (P<0.05) between group means 
within either DCPM or DIFN when a common letter is 
not present. Error bars indicate SEM 
64 
DCPM XIO^ 










- 80 z 
-60 b w Q 




in mediastinal lymph node cells, while calves in the live 
vaccine and convalescent groups had a higher DCPM in 
mediastinal than in superfical cervical lymph node cells 
(data not shown). 
Differences between experimental groups were present in 
proliferative responses averaged over superficial cervical 
and mediastinal lymph node cells stimulated with SON 
(P<0.03). The convalescent group DCPM was significantly 
higher than the DCPM of the unvaccinated, bacterin, or live 
vaccine group DCPM (data not shown). 
Gamma interferon responses 
Significant differences between experimental groups were 
not present for DIFN from culture supernatants of PBMC 
stimulated with OMP for any of the days analyzed (Days 11, 
18, and 25) (P>0.05) (data not shown). 
Differences in gamma interferon production between 
experimental groups were present from mediastinal lymph node 
cells stimulated with OMP (P<0.002) (Fig. 4). The highest 
DIFN occurred in the live vaccine group, which was 
significantly higher than the DIFN of the unvaccinated, 
bacterin or convalescent group. The convalescent group DIFN 
was also significantly higher than the DIFN of either the 
unvaccinated or bacterin group. 
Significant differences between experimental groups were 
not present in the DIFN of superficial cervical lymph node 
Fig. 4. Gamma interferon responses of superficial cervical 
and mediastinal lymph node cells stimulated with 
outer membrane protein (OMP) from P. haemolvtica. 
Calves were vaccinated or infected with £. 
haemolvtica 35 or 36 days prior to stimulation of 
lymph node cells. Values represent mean DIFN 
(difference of ng/ml of gamma interferon in antigen-
stimulated wells from background wells) by 
experimental group. There is a significant 
difference (P<0.05) between group means 
within a lymph node when a common letter is not 
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cells stimulated with OMP (P>0.05) (Fig. 4). 
Differences between experimental groups were present in 
DIFN averaged over superficial cervical and mediastinal lymph 
node cells stimulated with OMP (P<0.002) (Fig. 3). The live 
vaccine group average DIFN was significantly higher than the 
average DIFN of the unvaccinated, bacterin, or convalescent 
group. 
Necropsy findings 
Acute pneumonic lung consisted of consolidated 
parenchyma of ventral portions of the lobes, often 
accompanied by hemorrhage and fibrinous pleuritis. 
Microscopically, alveoli were filled with fibrin, 
neutrophils, macrophages, and ocassionally, streaming 
leukocytes. There were occasional foci of necrosis in the 
lung parenchyma, and interlobular septa and subpleural 
spaces were expanded by fibrinocellular exudate. The gross 
and microscopic lung lesions were consistent with previous 
descriptions of lesions associated with pneumonic 
pasteurellosis (19). The mean % pneumonia for each group 
was: unvaccinated - 25.1, bacterin - 10.5, live vaccine -
16.5, and convalescent - 0.1 (SEM=9.6). No signifificant 
differences occurred between experimental groups (P=0.37). 
Chronic lung lesions were present in two calves of the 
convalescent group, characterized by abscessation of ventral 
portions of all lung lobes. These lesions were consistent 
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with pneumonia of several weeks duration, as a result of 
infection of the calves with P. haemolvtica on day 0. 
Bacterial cultures of lungs revealed pure populations of 
P. haemolvtica. Mean CFU loq^^/q of lung by experimental 
group were: unvaccinated group - 4.9, bacterin group- 5.0, 
live vaccine group - 7.6, and convalescent group - 5.8 
(SEM=1.6). There were no significant differences (P=0.62) 
between the experimental group means. 
Correlations 
Correlation of DCPM or DIFN of OMP-stimulated 
mediastinal lymph node cells with % pneumonia was not 
significant (P>0.05) (Fig 5). Correlation of DCPM or DIFN of 
OMP-stimulated mediastinal lymph node cells with bacterial 
concentration in pneumonic lesions was not significant 
(P>0.05) (data not shown). Serum antibody titer on day 31 
and % pneumonia were significantly correlated, with r=-0.57 
(P=0.05) (Fig. 5). However, this correlation was markedly 
affected by one seronegative calf in the unvaccinated group 
that had 58% of the lung volume consolidated. With the data 
from this individual removed, a signficant correlation of 
antibody titer versus % pneumonia was not present, with 
r=0.07 (P=0.83). 
The DCPM of OMP-stimulated mediastinal lymph node cells 
approached a significant correlation with antibody titer on 
day 31, with R=0.59 (P=0.06), however the DIFN of OMP-
Fig. 5. correlation of proliferative (A), gamma interferon 
(B) or antibody response (C) with % pneumonia of 
calves after challenge exposure to P. haemolvtica 31 
days after calves were vaccinated or infected with 
P. haemolvtica. Mediastinal lymph node cells were 
stimulated with outer membrane protein (OMP) from 
P. haemolvtica 35 or 36 days after calves were 
vaccinated or infected with P. haemolvtica. 
Antibody titers on day 31 were determined by an 
indirect hemagglutination assay. The DCPM or DIFN 
represent the difference in CPM or ng of gamma 
interferon/ml of antigen-stimulated wells from 
background wells. Different symbols are used to 
identify the treatment group of the 
individuals. Correlation coefficients (r values) 
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stimulated mediastinal lymph node cells did not correlate 
significantly with antibody titer on day 31 (P>0.05), (Fig. 
6). The DIFN of OMP-stimulated mediastinal lymph node cells 
did not correlate significantly with the DCPM of OMP-
stimulated mediastinal lymph node cells (P>0.05) (Fig 6). 
Fig. 6. Correlation of proliferative or gamma interferon 
responses of calves with antibody titer (A and B) 
and correlation of proliferative responses with 
gamma interferon responses (C). Mediastinal lymph 
node cells were stimulated with outer membrane 
protein (OMP) from P. haemolvtica 35 or 36 days 
after calves were vaccinated or infected with P. 
haemolvtica. Serum antibody titers on day 31 were 
determined by an indirect hemagglutination assay. 
The DCPM or DIFN represent the difference in CPM or 
ng of gamma interferon/ml of antigen-stimulated 
wells from background wells. Different symbols are 
used to identify the treatment group of the 
individuals. Correlation coefficients (r values) 
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DISCUSSION" 
In this study, cattle vaccinated with a live P. 
haemolvtica vaccine or infected intratracheally with P. 
haemolvtica developed cell-mediated immune responses, as 
assessed by measuring proliferation and gamma interferon 
production by lymph node cells following incubation with 
certain P. haemolvtica antigens. Proliferative responses 
were significant when OMP and SON antigens but not when CP, 
LPS or LAP antigens were used to stimulate lymph node 
lymphocyte cultures. The lack of responsiveness of PBMC 
cultures in the present study may reflect a lack of effective 
antigen presenting cells in PBMC preparations (34). 
The highest proliferative responses were present in 
mediastinal lymph node cells of calves in the live vaccine 
group and the convalescent group. There was clinical 
evidence of pneumonia in all calves of the convalescent group 
and chronic pneumonia was present in two of three calves at 
necropsy. In cattle, the caudal mediastinal lymph node 
receives lymphatic flow from the lung (27), therefore, 
abundant P. haemolvtica antigen from pneumonic parenchyma 
should have been delivered to the caudal mediastinal lymph 
node of calves in the convalescent group. 
Calves in the bacterin group had higher proliferative 
responses in superficial cervical than in mediastinal lymph 
node cells, indicating that the immunologic responses were 
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localized near the site of administration of the bacterin. 
Conversely, calves in the live vaccine group had higher 
proliferative and gamma interferon responses in mediastinal 
than in superficial cervical lymph node cells, indicating 
that abundant antigen from P. haemolvtica was delivered to 
mediastinal lymph nodes for sensitization of T lymphocytes. 
It is likely that the live vaccine replicated in the lung, 
or, possibly, that blood-borne antigens were removed in the 
lung and transported to mediastinal lymph nodes. Pasteurella 
haemolvtica may cause pneumonia when inoculated intravenously 
into animals (13, 31), and it is possible that the live 
vaccine replicated in sites other than the site of 
vaccination. Administration of live P. haemolvtica vaccines 
has been associated with P. haemolvtica septicemia and 
meningitis in cattle (35). In the present study, calves 
vaccinated with the live vaccine had febrile responses after 
vaccination, as well as extensive tissue swelling at the site 
of vaccination; either may be associated with septicemia, but 
blood cultures were not performed on calves to determine if 
bacteremia occurred. 
Although relatively few animals were used in the present 
study, proliferative and gamma interferon responses did not 
correlate with the severity of pneumonia after challenge. 
These data provide no strong evidence for the role of CMI in 
protection against pneumonic pasteurellosis. However, one 
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animal in the unvaccinated group markedly affected the 
correlation between antibody titer and % pneumonia. When the 
data from this individual was removed for statistical 
analysis, the correlation between antibody titer and % 
pneumonia became less significant than the correlations 
between CMI responses and % pneumonia. Confer et al. (6) 
demonstrated that antibody responses of calves vaccinated 
with live P. haemolvtica correlated with protection against 
challenge with virulent organisms, whereas antibody responses 
of calves vaccinated with a killed bacterin did not correlate 
with protection. Numbers of calves in the present study, 
however, were not sufficient to allow correlations of immune 
responses of calves within experimental groups with 
protection against the challenge exposure. 
As an effector cytokine of the CMI response, gamma 
interferon may provide assistance in elimination of P. 
haemolvtica by enhancing phagocye uptake and killing of the 
organism. Gamma interferon has been shown to enhance 
cellular antimicrobial activities against some bacterial 
species, including Mycobacterium bovis (14) and Listeria 
monocytogenes (26). Administration of gamma-interferon to 
mice has been shown to reduce infection rates after challenge 
with Brucella abortus (28). When administered to cattle, 
recombinant bovine gamma interferon reduced the severity of 
pneumonia in dexamethasone-treated calves that were 
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challenged with Haemophilus somnus (4). In the present 
study, the in vitro gamma interferon response was highest in 
calves from the live vaccine group, although calves in this 
group did not have significantly less pneumonia after 
challenge than those in the groups with lower gamma 
interferon responses. Although gamma interferon has been 
shown to facilitate killing of intracellular pathogens, it's 
effect on cellular defenses against P. haemolvtica is 
unknown. Pasteurella haemolvtica survives and replicates in 
the extracellular environment (8); therefore, the beneficial 
bactericidal-enhancing effects of gamma-interferon may not be 
as significant for P. haemolvtica as for facultative 
intracellular bacteria such as Brucella or Listeria species. 
In this study, CMI responses to P. haemolvtica were 
detected and quantitated in vitro, using lymph node-derived 
lymphocytes. Further studies are necessary to determine the 
role of CMI alone or in conjunction with humoral immune 
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GENERAL DISCUSSION AND SUMMARY 
The first of the two studies demonstrates that the goat 
may serve as a suitable model for studies of bovine pneumonic 
pasteurellosis, with all of three goats developing pneumonia 
after intratracheal inoculation with P. haemolvtica. 
Furthermore, one of three goats that was inoculated 
intravenously developed pneumonia, supporting the study by 
Thomas et al. (1989) in which cattle developed pneumonia 
subsequent to intravenous inoculation with P. haemolvtica. 
Although experimental studies demonstrate that P. haemolvtica 
can cause pneumonia when inoculated into ruminants by the 
intravenous route, the probability of an intravascular route 
of the organism to the lung in natural cases must be 
questioned. Pneumonia was not demonstrated in goats that 
were intratonsillarly-inoculated with £. haemolvtica in the 
present study, providing no evidence of invasion of the 
tonsil as a route of access of the organsim to the lung. 
Lymphoid tissues, however, have been demonstrated to be a 
portal of entry of other pathogens (Ackermann et al., 1988, 
Momotani et al., 1988, Woode et al., 1984). 
In the second study of the dissertation, there was 
evidence of accession of antigens of P. haemolvtica to the 
lung after vaccination of calves with a live P. haemolvtica 
vaccine. Proliferative and gamma interferon responses of 
mediastinal lymph node cells from calves vaccinated with the 
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live P. haemolvtica vaccine indicated a likely replication of 
the vaccine-derived bacteria in the lung. A vascular route 
of the organism to the lung is likely, and ruminants have 
abundant pulmonary intravascular macrophages, which cause a 
high percentage of intravascular bacteria to be removed from 
the blood by the lung (Warner et al., 1987). In the present 
study, however, it was not determined if calves vaccinated 
with the live vaccine developed pneumonia. 
In the second study of this dissertation, CMI responses 
were demonstrated from calves after vaccination with a live 
vaccine or after inoculation of calves with virulent P. 
haemolvtica via the respiratory tract. The CMI responses 
were demonstrated either by assessment of lymph node 
lymphocyte proliferation or gamma interferon production 
subsequent to in vitro stimulation with OMP or SON antigens 
extracted from P. haemolvtica. This is the first published 
study of CMI responses of cattle to P. haemolvtica. Numerous 
studies have reported on humoral immune responses to P. 
haemolvtica. and antibody responses to leukotoxin or antigens 
present on the surface of P. haemolvtica have been associated 
with protection against pneumonic pasteurellosis (Confer et 
al., 1985b, Gentry et al., 1985). However, concurrent but 
unassessed CMI responses may have been present that may have 
also contributed to the protection against challenge. 
Although neither lymphocyte proliferative or gamma interferon 
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responses correlated strongly with protection against 
challenge with P. haemolvtica in the present study, neither 
did antibody responses correlate strongly with protection. 
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APPENDIX 1 
MATERIALS AND METHODS FROM PAPER 1 
Ten colostrum-deprived, crossbred goats were reared in 
isolation until the study was initiated when goats were 14-18 
weeks of age. Pasteurella haemolvtica was not isolated from 
nasal swabs obtained from the goats prior to inoculation with 
P. haemolvtica. Prior to inoculation of goats with P. 
haemolvtica. antibody levels to £. haemolvtica were 
determined by indirect hemagglutination. Seven goats had 
titers ranging from 1:4 to 1:16. Goats were randomly 
assigned to three treatment groups of three goats per group, 
with one goat remaining as a sham inoculated control. Goats 
were housed indoors under controlled environmental 
conditions, with all individuals in each treatment group in a 
separate room. Goats were euthanatized intravenously with 
pentobarbital and necropsied 42-66 hours after inoculation 
with P. haemolvtica. 
Pasteurella haemolytica A1 (isolate LlOl) was isolated 
from pneumonic bovine lung and first passage colonies were 
inoculated into tryptose broth and frozen at -70 C. For 
preparation of inocula, organisms were thawed and inoculated 
into tryptose broth. After 6 hours incubation at 37 C, 
bacteria were pelleted by centrifugation at 5900 X g for 5 
minutes at 4 C. Organisms were washed two times in tryptose 
broth, and inocula were adjusted to 80% transmittance at a 
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wavelength of 600 nm in tryptose broth, and were then 
serially diluted to inoculation concentrations. Inocula were 
maintained on ice until inoculated into goats, which was less 
than 1 hour after preparation. Concentration of organsims in 
inocula was confirmed by standard plate counts. Goats that 
were inoculated intratracheally and intravenously were given 
10 ml of an inoculum containing 2.0 X 10® CFU of P. 
haemolvtica. while goats that were inoculated 
intratonsillarly were given O.l ml of inoculum containing 2.3 
X 10^ CFU in each palatine tonsil. For intratracheal 
inoculation, an 18 gauge, 1 inch needle was inserted into the 
tracheal lumen approximately 3-5 cm below the larynx, and the 
inoculum was delivered over a period of approximately 5 
seconds. Inoculum was delivered slowly into the jugular vein 
of intravenously-inoculated goats. Goats that were 
inoculated intratonsillarly were sedated with 0.25 mg 
xylazine intravenously, then were placed in lateral 
recumbency. Inoculum was placed in the external orifice of 
each palatine tonsil with a 1 ml plastic pipette which had 
the tip slightly curved and blunted to avoid traumatizing the 
surrounding mucosa. A laryngoscope was used to allow access 
to the palatine tonsils. The control goat was inoculated 
with sterile tryptose broth; 10 ml was given both 
transtracheally and intravenously, and 0.1 ml was given 
intratonsillarly. 
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Venous blood was collected from all goats in sterile 
sodium citrate for quantitative bacterial culture at 1 
minute, 30 minutes, 2 hours, and 24 hours after inoculation 
with P. haemolytica. Blood was collected from the jugular 
vein, contralateral to the site of inoculation of 
intravenously-inoculated goats, and maintained on ice until 
cultured. Within one hour after collection, 0.1 ml of blood 
was spread onto each of two 5% sheep blood agar plates and 
incubated at 37 C for 24 hours. 
Samples of lung (from gross lesions if available), 
liver, kidney, spleen, brain and palatine tonsil were 
homogenized with tryptose broth using sterile Ten Broeck 
tissue grinders. Ten-fold dilution of homogenized tissue 
were spread onto each of two sheep blood agar plates for 
isolation of P. haemolvtica. Colonies were identified by 
typical morphology, the presence of typical morphology and 
minimal incomplete hemolysis, and rapid slide agglutination 
with antiserum. 
Rectal temperatures were taken twice daily on all goats 
after inoculation, and goats were observed at least twice 
daily for clinical signs of disease. At necropsy, internal 
organs were examined for gross lesions. The percentage of 
consolidated lung for each goat was estimated by gross 
examination of the lung after removal from the carcass. 
Sections of lung, liver, kidney, spleen, brain and palatine 
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tonsil were collected in 10% buffered neutral formalin, and 
processed and sectioned for histopathology by standard 




SERUM LEUKOTOXIN NEUTRALIZATION ASSAY 
Serum leukotoxin neutralization titers were determined 
on serum samples taken from calves of the study presented in 
Paper 2 of this dissertation. The titers were determined 
using a leukotoxin neutralization assay with BL-3 cells as 
toxin-sensitive cells, by methods developed by R. E. Briggs, 
Ames, lA. 
Stock P. haemolvtica A1 (OSU strain) leukotoxin was 
thawed and titrated to determine the concentration necessary 
to kill 30-70% of BL-3 cells (kindly provided by S. R. Bolin, 
Ames, lA) that had been passaged the previous day. 
Additional leukotoxin was thawed and diluted to eight times 
the titer necessary to kill 30-70% of the BL-3 cells. In 96-
well plates, toxin was added for one hour at 25 C to serum 
samples that were diluted in Earle's Balanced Salt Solution 
(EBSS, Sigma Chemical Co., St. Louis, MO). The BL-3 cells 
that had been washed once in EBSS were then added to wells at 
a concentration of 2 X 10® cells in a volume equal to the 
combined volume of serum and toxin present in the wells. 
Plates were then incubated at 37 C with constant shaking. 
After one hour, plates were centrifuged at 1000 X g for 10 
minutes and the supernatants were discarded. l-[4,5-
dimethylthiazol-2-yl] - 3,5 diphenylformazan (MTT, Sigma 
Chemical Co., St. Louis, MO) was then added to the wells at 
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100 ug/well in 100 ul of RPMI. Cells were incubated with the 
MTT at 37 C, with constant shaking, for 90 minutes. Plates 
were then centrifuged, supernatants were discarded, and 100 
ul of dimethylsulfoxide (DMSO, Sigma Chemical Co., St. Louis, 
MO) was added. Plates were incubated at 25 C for 5 minutes 
with constant shaking, then absorbance was determined at a 
dual wavelength (550-650 nm). Anti-leukotoxin titers were 
determined at the serum dilution where 30-70% of the BL-3 
cells were killed. For standards, 100% of cells killed was 
determined by adding sonicated BL-3 cells to wells, and 0% of 
cells killed was determined by including no toxin in the 
wells. Positive control wells were included on each plate, 
to which toxin was added to cells in the absence of serum. 
Mean antileukotoxin titers are presented by treatment group 
(Fig. 7), followed by correlations of antileukotoxin titers 
versus % pneumonia, DCPM, DIFN, and serum IHA titers to P. 
haemolvtica (Figs. 8 and 9). 
Fig. 7. Mean serum antileukotoxin antibody titers of calves 
by experimental group as determined by a toxin 
neutralization assay. Calves were vaccinated or 
infected with P. haemolvtica on day 0, and calves in 
the bacterin group were re-vaccinated on day 15. 
There is a significant difference (P<0.05) between group 
means within a day when a common letter is not 



























Fig. 8. Correlation of proliferative (A), gamma interferon 
(B) or IHA antibody response (C) with antileukotoxin 
antibody response of calves after challenge exposure 
to P. haemolvtica. 31 days after calves were 
vaccinated or infected with P. haemolvtica. 
Mediastinal lymph node cells were stimulated with 
outer membrane protein (OMP) from P. haemolytica 35 
or 36 days after calves were vaccinated or infected 
with P. haemolvtica. Serum IHA antibody titers on 
day 31 were determined by an indirect 
hemagglutination assay, and serum antileukotoxin 
antibody titers on day 25 were determined by a 
leukotoxin neutralization assay. The DCPM or DIFN 
represent the difference in CPM or ng of gamma 
interferon/ml of background wells. Different symbols 
are used to identify the treatment group of the 
individuals. Correlation coefficients (r values) 
are statistically significant when P<0.05 
Log; Antileukotoxin Titer Log; Antileukotoxin Titer Log; Antileukotoxin Titer 
Fig. 9. Correlation of antileukotoxin antibody response with 
% pneumonia of calves after challenge exposure to P. 
haemolvtica. 31 days after calves were vaccinated or infected 
with P. haemolytica. Serum antileukotoxin antibody titers on 
day 25 were determined by a leukotoxin neutralization assay. 
Different symbols are used to identify the treatment group of 
the individuals. Correlation coefficients (r values) are 
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APPENDIX 3 
FIXATION OF BOVINE NASAL MUCUS IN SITU 
Under certain conditions, P. haemolytica colonizes the 
upper respiratory tract of cattle, and serves as the source 
of organisms that gain access to the lung. Mechanisms of 
colonization by £. haemolvtica are poorly defined, although 
fimbriae have been described on P. haemolvtica by one group 
of investigators. 
The upper respiratory tract has a discontinuous mucus 
blanket that overlies the epithelial cell surfaces and 
entraps foreign debris and bacteria. The mucus blanket is 
propelled by motile cilia, resulting in removal of entrapped 
debris and bacteria. 
It is not known whether P. haemolvtica adheres to and 
colonizes epithelial cell surfaces, or if the organism 
colonizes the mucus blanket that overlies the cells. The 
purpose of this group of experiments was to develop 
techniques to fix nasal mucosa with in situ retention of the 
mucus blanket. Once the normal mucus blanket was preserved, 
morphologic studies could be performed to localize the 
colonized bacteria. 
In most of the experiments, anti-bovine mucus antiserum 
was used to aid in retention of the mucus blanket. 
Theoretically, anti-mucus antibodies should cross-link the 
mucus structure to stabilize it on the epithelial cell 
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surface. Anti-bovine mucus antiserum was prepared in guinea 
pigs by the following methods. Nasal exudate was collected 
from the nares of a gnotobiotic calf housed in a sterile 
isolation apparatus. The exudate was lyophilized and 
resuspended in phosphate buffered saline to yeild a 2 mg/ml 
concentration of nasal exudate. The resuspended exudate was 
mixed with an equal volume of Freund's complete adjuvant and 
0.1 ml was injected intradermally in 10 locations in each of 
5 guinea pigs. The injection procedure was repeated 10 days 
later, then the guinea pigs were anesthetized and 
exsanguinated 7 days after the second immunization. Serum 
was harvested from all 5 guinea pigs and pooled. Evaluation 
of the antiserum by agar gel immunodiffusion revealed 
prominent bands of identity when the nasal exudate was used 
as the antigen. 
Preparation of the tissues for microscopic examination 
was repeated by similar methods, as follows, unless otherwise 
noted. Briefly, the tissues were trimmed to approximately 1 
X 2 micrometers, immersed in 1% osmium tetroxide for 1 hour, 
dehydrated in graded alcohols, and embedded in Epon. Tissues 
were then sectioned at 2 microns thickness and stained with 
toluidine blue for examination by light microscopy. 
Experiment 1 
A bovine head was received from a local abbatoir, and 
circular sections of nasal mucosa from sites on the ventral 
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turbinate and nasal septum were removed and immersed in the 
anti-mucus antiserum or saline for 2.5 hours. Sections were 
placed in 2.5% glutaraldehyde for 18 hours, then prepared for 
microscopic examination. None of three sections treated with 
anti-mucus antiserum or three sections treated with saline 
had visible mucus overlying the epithelial cells when 
examined. 
Experiment 2 
Techniques used were as those described in experiment l, 
except metal serum vial covers were applied to the nasal 
mucosal surface of the nasal septum to serve as reservoirs 
for the anti-mucus antiserum, which was applied for 1.5 
hours. Normal guinea pig serum was applied to additional 
vial covers to serve as controls. The metal covers were 
removed, and the mucosal sections were excised and fixed for 
4 hours in 2.5% glutaraldehyde. Tissues were then prepared 
for microscopic examination. Four of 4 sections fixed with 
anti-mucus antiserum had variable amounts of mucus retained, 
while 0 of 2 sections fixed with normal guinea pig serum had 
mucus present. 
Experiment 3 
A calf of approximately 4 months age was euthanatized 
and the head was removed immediately after death. Metal 
serum vial covers were applied to the nasal mucosa of the 
nasal septum, and anti-mucus antiserum was applied to the 
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mucosa for 2 hours, followed by application of 2.5% 
glutaraldehyde to the metal caps for an additional 3 hours. 
The mucosal sections were excised and immersed in 2.5% 
glutaraldehyde for 18 hours, then were prepared for 
microscopy. One of 3 sections treated with anti-mucus 
antiserum had a minimal amount of mucus present, while none 
of the sections treated with normal guinea pig serum had 
mucus present. 
Experiment 4 
Two calves that were inoculated with BHV-1 and P. 
haemolvtica were euthanatized, and their heads^ were removed 
immediately after death. Metal serum vial covers were 
applied to the nasal mucosa of the nasal septum, and 
experimental procedures used in Experiment 3 were repeated. 
In one calf, 4 of 9 sections treated with anti-mucus 
antiserum had minimal mucus present, while none of 8 section 
treated with normal guinea pig serum had mucus present. 
Mucosal sections from the second calf had minimal mucus 
present in 3 of 6 sections, while 1 section of 8 treated with 
normal guinea pig serum had minimal mucus overlying the 
epithelial cells. 
Experiment 5 
Two calves of approximately 7 months age were 
euthanatized, and their heads were removed immediately after 
death. Metal serum vial covers were applied to the nasal 
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mucosa of the nasal septum, and 20 ul of 10% buffered neutral 
formalin was applied to each serum vial cover to arrest 
ciliary activity. Anti-mucus antiserum was then added to the 
covers for 2 hours, then mucosal sections were excised and 
immersed in 2.5% glutaraldehyde for 18 hours. The mucosal 
sections were then prepared for microscopy. Mucosal sections 
from one calf had minimal mucus present in 5 of 9 sections, 
while only 1 of 10 sections treated with normal guinea pig 
serum had mucus present. From the second calf, one of 3 
sections treated with anti-mucus antiserum had minimal mucus 
present, while none of 3 sections treated with normal guinea 
pig serum had mucus present. 
Experiment 6 
A calf of approximately 7 months age was euthanatized, 
and the head was removed immediately after death. Metal 
serum vial covers were applied to the nasal mucosa of the 
nasal septum. The covers had anti-mucus antiserum, 25% 
glutaraldehyde, Carnoy's fixative, 95% ethanol, or 100% 
acetone applied for two hours. Caps were removed, and 
mucosal sections were excised. Those treated with antiserum 
or 25% glutaraldehyde were then immersed for 4 hours in 2.5% 
glutaraldehyde, while all others were immersed in the same 
fixative that was applied to the respective ring. Sections 
were then prepared for microscopy. Two of 3 sections treated 
with anti-mucus antiserum had minimal mucus present, while 2 
129 
of 2 sections fixed with 100% acetone had a blanket of 
material resembling mucus overlying the epithelium. Marked 
cellular artifact was induced by the acetone treatment. 
Neither of each of two sections treated with 25% 
glutaraldeyhde, Carnoy's fixative, or 95% ethanol had mucus 
present. 
Experiment 7 
Two bovine heads were received from a local abbatoir. 
The nasal mucosa of the nasal septum from one head was 
sprayed with an aerosol of 37% formaldehyde. Metal serum 
vial covers were applied to the nasal mucosa of the nasal 
septum of both heads and anti-mucus antiserum was applied for 
two hours. Mucosal sections were then excised and immersed 
in 2.5% glutaraldehyde for 18 hours, then were prepared for 
microscopy. Two of 6 sections that were vaporized with 
formaldehyde and treated with anti-mucus antiserum had 
minimal mucus present, while 2 of 5 sections treated with 
anti-mucus antiserum without vaporization with formaldehyde 
had minimal mucus present. 
Experiment 8 
An adult cow was euthanatized and the head was removed 
immediately after death. A nebulizer delivering 2.5% 
glutaraldehyde was attached to the external nares to 
aersolize the fixative through the nasal cavity, allowing 
aerosolized fixative to flow out through the bisected 
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trachea. After aersolization for 1.5 hours, metal serum vial 
covers were applied to the nasal mucosa of the nasal septum, 
and anti-mucus antiserum, 2.5% glutaraldehyde, 50% acetone, 
or 100% acetone was applied to the covers for 2 hours. 
Mucosal sections were then preapred for microscopy. Two of 3 
sections treated with anti-mucus antiserum had mucus present, 
one of which had a linear blanket of mucus covering 
approximately one-half of the section. Two of 3 sections in 
which glutaraldehyde was applied to the rings had a minimal 
amount of mucus present. None of 2 sections treated with 50% 
acetone had mucus present, while 2 of 2 sections treated with 
100% acetone had mucus present, although artifactual changes 
were present in epithelial cells. 
Experiment 9 
An adult goat was euthanatized and the head was removed 
immediately after death. Sections of nasal mucosa from the 
nasal septum were excised and placed in isopentane that was 
cooled with liquid nitrogen to a point slightly above the 
freezing point of the isopentane. Nasal mucosal sections 
were then frozen in the isopentane, then transferred to 
acetone at -70 C and stored for 96 hours. Mucosal sections 
were then embedded in glycol methacrylate by standard 
methods, maintaining the tissue below 0 C until embedded. 
Tissues were sectioned at 2 micrometers thickness and stained 
with hematoxylin and esoin by standard methods. Three of 
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three sections had a blanket of mucus overlying the 
epithelial cells. The mucus layer was composed of fibrillary 
material, possibly because of artifactual changes induced in 
the mucus by freezing. 
In conclusion, methods using anti-mucus antiserum to 
preserve the mucus layer for morphologic examination resulted 
in increased retention of mucus overlying the epithelium, but 
a consistent blanket of mucus was generally not retained. 
Methods of freezing the tissue in isopentane with embedding 
in glycol methacrylate were superior in retention of the 
mucus layer, although artifactual changes were present in the 
mucus layer. 
